Table 1.

Patient baseline characteristics and demographics (n = 56)

Factors	Description
Gender
Male	77% (n = 43)
Female	23% (n = 13)
Age
Age (years)	Median, 64; range 24–86
Smoker
Yes	77% (n = 43)
No	23% (n = 13)
Diabetic
Yes	5% (n = 3)
No	95% (n = 53)
Primary site
Rinopharynx	9% (n = 5)
Oropharynx	30% (n = 17)
Oral cavity	18% (n = 10)
Larinx sovraglottic	9% (n = 5)
Larinx glottic	30% (n = 17)
Salivary glands	4% (n = 2)
Histology
Epidemoidal	88% (n = 49)
Others	13% (n = 7)
Grading
Grade 1	27% (n = 15)
Grade 2	46% (n = 26)
Grade 3	27% (n = 15)
Stage
I	20% (n = 11)
II	13% (n = 7)
III	18% (n = 10)
IVA	46% (n = 26)
IVB	4% (n = 2)
Chemotherapy
Cisplatino weekly	20% (n = 11)
Cisplatino 3-weekly	32% (n = 18)
Induction	2% (n = 1)
None	46% (n = 26)
Radiotherapy
Radical	71% (n = 40)
Adjuvant	29% (n = 16)